Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Diabetes ; 30(2): 101-5, 1981 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7009264

RESUMO

We have studied the effects of mixed meals and dextrose intake on blood glucose and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. A group of 12 patients had 3 mixed meals containing at random 20, 40, and 60 g of complex carbohydrate along with protein and fat; another group of 12 diabetics, comparable in weight, age, and duration of diabetes, received at random 20, 40, and 60 g of dextrose. Dextrose ingestion led to a higher initial blood glucose increase than did the mixed meal, but the duration of blood glucose increase lasted significantly longer after the mixed meal than after the dextrose load. The areas under the curves of hyperglycemia were not significantly different. There was a high (but not linear) correlation between the total amount of insulin delivered in order to restore initial blood glucose values and the amount of CHO consumed. There was no correlation with age, body weight, duration of diabetes, nor with the nature and order of administration of the CHO load; 5.1 +/- 1.6 to 13.7 +/- 2.1 units of insulin were needed for a period of 94 +/- 11 to 132 +/- 11 min. It is suggested that some of the data obtained in this study might be useful in the programming of an open-loop insulin infusion system.


Assuntos
Órgãos Artificiais , Diabetes Mellitus/tratamento farmacológico , Carboidratos da Dieta/metabolismo , Insulina/administração & dosagem , Pâncreas/metabolismo , Adulto , Glicemia/metabolismo , Carboidratos da Dieta/administração & dosagem , Feminino , Glucose , Humanos , Insulina/uso terapêutico , Masculino
2.
J Radiol ; 76(7): 431-4, 1995 Jul.
Artigo em Francês | MEDLINE | ID: mdl-7473377

RESUMO

Gadodiamide injection (Gd-DTPA-BMA) is a new non-ionic paramagnetic contrast agent for which the safety at the dose 0.1 mmol/kg was evaluated during a European multicentre study on a large population of adult patients who had an MR examination of the central nervous system with contrast medium. The safety analysis was performed on 2,102 patients by recording the adverse events observed during injection and up to 24 hours after the injection. Adverse events due or probably due to gadodiamide injection were observed in 102 patients (4.4%) with injection-site associated discomfort (heat, coldness, pain at the injection site) in 37 patients (1.8%) and adverse events other than discomfort (headache, nausea, vomiting) in 35 patients (3.1%). No adverse events of severe intensity or death were reported during the trial. Gadodiamide injection was shown to be safe and well tolerated and represents a non-ionic alternative to the current products in the field of MR imaging of the central nervous system.


Assuntos
Doenças do Sistema Nervoso Central/induzido quimicamente , Gadolínio DTPA , Imageamento por Ressonância Magnética , Compostos Organometálicos/efeitos adversos , Ácido Pentético/análogos & derivados , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças do Sistema Nervoso Central/diagnóstico , Meios de Contraste , Feminino , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Compostos Organometálicos/administração & dosagem , Ácido Pentético/administração & dosagem , Ácido Pentético/efeitos adversos
3.
Ann Endocrinol (Paris) ; 41(5): 355-61, 1980.
Artigo em Francês | MEDLINE | ID: mdl-7235617

RESUMO

The case reported concerns a man in whom appeared gradually, since the age of twenty-seven years, difficulty in walking and sexual impotence. The neurological syndrome consisted of pyramidal signs and objective sensory disorders of the lower limbs, intermittent sphincter disorders and mild mental deterioration, which was progressive. Biopsy of a sensory nerve showed rarefaction of myelinated fibres. The endocrine syndrome consisted of peripheral adrenal insufficiency, which was undoubted but with biologic evidence only. There was no response of plasma cortisol during five stimulation tests with tetracosactide and there was a gradual rise in plasma A.C.T.H. The clinical picture was thus that of an adrenomyeloneuropathy.


Assuntos
Insuficiência Adrenal/complicações , Doenças Desmielinizantes/complicações , Esclerose Cerebral Difusa de Schilder/complicações , Insuficiência Adrenal/sangue , Insuficiência Adrenal/diagnóstico , Adulto , Doenças Desmielinizantes/diagnóstico , Doenças Desmielinizantes/genética , Esclerose Cerebral Difusa de Schilder/diagnóstico , Humanos , Masculino
4.
Ann Endocrinol (Paris) ; 40(1): 77-8, 1979.
Artigo em Francês | MEDLINE | ID: mdl-443745

RESUMO

Adrenoleukodystrophy (Schilder-Addison's disease) is a sex-linked recessive syndrome usually observed in children, associating neurological disorders and Addison's disease. Its outcome is death after a few years. The authors report the case of a man in whom a spastic paraparesis and a mental deterioration appeared at the age of 30 years. A biological adrenal deficiency was found: plasma cortisol and urinary 17-hydroxy-steroids and 17-ketosteroids failed to increase after synacthen stimulation; plasma ACTH level was above normal. Since two nephews of the patient suffered from adrenoleukodystrophy, the same disease is likely in the reported patient.


Assuntos
Doença de Addison/complicações , Esclerose Cerebral Difusa de Schilder/complicações , Doença de Addison/diagnóstico , Adulto , Esclerose Cerebral Difusa de Schilder/diagnóstico , Humanos , Masculino
5.
Neuroradiology ; 38(6): 537-41, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8880714

RESUMO

Gadodiamide injection is a new nonionic paramagnetic, extracellular contrast medium. Its safety at a dose of 0.1 mmol/kg body weight was evaluated in a large European multicentre trial on adults referred for contrast-enhanced MRI of the central nervous system. Safety analysis was performed on 2102 patients, in whom adverse events during and up to 24 h after injection were recorded. Adverse events related or possibly related to gadodiamide injection were observed in 102 patients. Injection-associated reactions classified as discomfort (sensation of heat or coldness, pain or pressure at the injection site) occurred in 37 patients (1.8%) and other adverse events (e.g. headache, nausea) were observed in 65 patients (3.1%). No serious adverse event was reported. Efficacy analysis, performed on 2273 patients, and based on comparison of T1- and T2-weighted images before and T1-weighted images after injection showed that more diagnostic information was obtained after gadodiamide injection in 1424 (62.6%) patients: management of 386 (17.0%) patients was affected by the new information given and that a new diagnosis was made in 755 (33.3%) patients. Gadodiamide injection was shown to be safe and well tolerated. It represents a nonionic alternative to the current products for MRI of the central nervous system.


Assuntos
Doenças do Sistema Nervoso Central/diagnóstico , Meios de Contraste/efeitos adversos , Gadolínio DTPA , Imageamento por Ressonância Magnética , Compostos Organometálicos/efeitos adversos , Ácido Pentético/análogos & derivados , Adolescente , Adulto , Sistemas de Notificação de Reações Adversas a Medicamentos , Idoso , Idoso de 80 Anos ou mais , Europa (Continente) , Feminino , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Ácido Pentético/efeitos adversos
6.
Acta Radiol ; 38(2): 273-4, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9093164

RESUMO

We report on a case of transient global amnesia after cerebral angiography in which a nonionic contrast medium was used. The complication observed showed no evidence of any definite cause.


Assuntos
Amnésia/etiologia , Angiografia Cerebral/efeitos adversos , Meios de Contraste/efeitos adversos , Humanos , Iohexol/efeitos adversos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA